Related Experiment Video
Updated: Feb 8, 2026
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment
Alireza Tahamtan1,2, Majid Teymoori-Rad3, Britt Nakstad4,5
1Infectious Diseases Research Centre, Golestan University of Medical Sciences, Gorgan, Iran.
Abstract:
Inflammation is a complicated biological and pathophysiological cascade of responses to infections and injuries, and inflammatory mechanisms are closely related to many diseases. The magnitude, the complicated network of pro- and anti-inflammatory factors, and the direction of the inflammatory response can impact on the development and progression of various disorders. The currently available treatment strategies often target the symptoms and not the causes of inflammatory disease and may often be ineffective. Since the onset and termination of inflammation are crucial to prevent tissue damage, a range of mechanisms has evolved in nature to regulate the process including negative and positive feedback loops. In this regard, microRNAs (miRNAs) have emerged as key gene regulators to control inflammation, and it is speculated that they are fine-tune signaling regulators to allow for proper resolution and prevent uncontrolled progress of inflammatory reactions. In this review, we discuss recent findings related to significant roles of miRNAs in immune regulation, especially the potential utility of these molecules as novel anti-inflammatory agents to treat inflammatory diseases. Furthermore, we discuss the possibilities of using miRNAs as drugs in the form of miRNA mimics or miRNA antagonists.
Insights
MicroRNAs (miRNAs) are key regulators of inflammation, offering potential as novel anti-inflammatory drugs. This review explores their role in immune regulation and therapeutic applications for inflammatory diseases.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Inflammation is a complex biological response to injury or infection, implicated in numerous diseases.
- Current treatments often manage symptoms rather than underlying causes of inflammatory disorders.
- Effective regulation of inflammation's onset and resolution is critical for preventing tissue damage.
Purpose of the Study:
- To review the significant roles of microRNAs (miRNAs) in regulating immune responses.
- To explore the potential of miRNAs as novel therapeutic agents for treating inflammatory diseases.
- To discuss the use of miRNA mimics and antagonists as potential drug modalities.
Main Methods:
- Literature review of recent findings on miRNA function in inflammation.
- Analysis of miRNA involvement in immune system regulation.
- Evaluation of therapeutic strategies utilizing miRNAs for inflammatory conditions.
Main Results:
- MicroRNAs (miRNAs) act as crucial gene regulators, fine-tuning inflammatory signaling pathways.
- Dysregulation of miRNAs is linked to the development and progression of various inflammatory disorders.
- miRNAs play a vital role in both promoting and resolving inflammatory reactions.
Conclusions:
- MicroRNAs (miRNAs) are essential for maintaining immune homeostasis and controlling inflammation.
- miRNA-based therapies, including mimics and antagonists, hold significant promise for treating inflammatory diseases.
- Targeting miRNAs represents a novel strategy to address the root causes of inflammatory conditions.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
02:41Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
Published on: May 3, 2024
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...